Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
Miren Ettcheto(Universitat de Barcelona), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Carme Auladell(Biomedical Research Networking Center on Neurodegenerative Diseases), Elena Sánchez‐López(Centro de Investigación Biomédica en Red), Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), Jaume Folch(Biomedical Research Networking Center on Neurodegenerative Diseases), Rubén D. Castro‐Torres(Universidad de Guadalajara), Carlos Beas‐Zárate(Universidad de Guadalajara), Jordi Olloquequi(University of Chile), Mònica Bulló(Institut de Recerca Biomèdica Catalunya Sud), Oriol Busquets(Biomedical Research Networking Center on Neurodegenerative Diseases), María L. García(Biomedical Research Networking Center on Neurodegenerative Diseases), Patrícia Regina Manzine(Universidade Federal de São Carlos)
Cited by 73
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
|Nutrition Reviews|2017|414
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325